Literature DB >> 19076175

Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome.

P T Murphy, S Mitra, M Gleeson, R Desmond, D W Swinkels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19076175     DOI： 10.1111/j.1365-2141.2008.07455.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Hepcidin levels and their determinants in different types of myelodysplastic syndromes.

Authors:  Valeria Santini; Domenico Girelli; Alessandro Sanna; Nicola Martinelli; Lorena Duca; Natascia Campostrini; Agostino Cortelezzi; Michela Corbella; Alberto Bosi; Gianluigi Reda; Oliviero Olivieri; Maria Domenica Cappellini
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

2.  New insights on iron study in myelodysplasia.

Authors:  Noha M El Husseiny; Dina Ahmed Mehaney; Mohamed Abd El Kader Morad
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

Review 3.  Myelodysplasia is in the niche: novel concepts and emerging therapies.

Authors:  E Bulycheva; M Rauner; H Medyouf; I Theurl; M Bornhäuser; L C Hofbauer; U Platzbecker
Journal:  Leukemia       Date:  2014-11-14       Impact factor: 11.528
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.